Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Epithelial neoplasms of the scalp account for approximately 2% of all skin cancers and for about 10‐20% of the tumors affecting the head and neck area. Radiotherapy is suggested for localized cutaneous squamous cell carcinomas (cSCC) without lymph node involvement, multiple or extensive lesions, for patients refusing surgery, for patients with a poor general medical status, as adjuvant for incompletely excised lesions and/or as a palliative treatment. To date, prognostic risk factors in scalp cSCC patients are poorly characterized.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To identify patterns of patients with higher risk of post‐radiotherapy recurrence</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>A retrospective observational study was performed on scalp cSCC patients with histological diagnosis who underwent conventional radiotherapy (50‐120 kV) (between 1996 and 2008, follow‐up from 1 to 140 months, median 14 months). Out of the 79 enrolled patients, 22(27.8%) had previously undergone a surgery. Two months after radiotherapy, 66(83.5%) patients achieved a complete remission, 6(7.6%) a partial remission, whereas 2(2.5%) proved non‐responsive to the treatment and 5 cases were lost to follow‐up. Demographical and clinical data were preliminarily analyzed with classical descriptive statistics and with principal component analysis. All data were then re‐evaluated with a machine learning‐based approach using a 4<sup>th</sup> generation artificial neural networks(ANNs)‐based algorithm. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>ANNs analysis revealed four scalp cSCC profiles among radiotherapy responsive patients, not previously described: namely, 1) stage T2 cSCC type, aged 70‐80 years; 2) frontal cSCC type, aged <70 years; 3) non‐recurrent nodular or nodulo‐ulcerated, stage T3 cSCC type, of the vertex and treated with >60 Grays (Gy); and 4) flat, occipital, stage T1 cSCC type, treated with 50‐59 Gy. The model uncovering these four predictive profiles displayed 85.7% sensitivity, 97.6% specificity, and 91.7% overall accuracy.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Patient profiling/phenotyping with machine learning may be a new, helpful method to stratify patients with scalp cSCCs who may benefit from a RT‐treatment.</p></section>

Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP models

Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor

Scalp dose analysis for transient and permanent alopecia following conventional cranial irradiation using Image Guided Radiotherapy (IGRT): A prospective study

Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model

Outcomes and Genomic Landscape of Patients Treated with Re-Irradiation for Recurrent Head and Neck Cancer Using Pencil Beam Scanning Proton Therapy: The Maryland Proton Treatment Center Experience

Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy

IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis

Radt-37. Proton Therapy Reirradiation For Recurrent Malignant Glioma: Prospective Analysis From The Proton Collaborative Group

Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma

Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors - Identification of high-risk patients and risk mitigation

Artificial neural networks allow response prediction in squamous cell carcinoma of the scalp treated with radiotherapy

A deep-learning-based surrogate model for Monte-Carlo simulations of the linear energy transfer in primary brain tumor patients treated with proton-beam radiotherapy

Does time to retreatment matter? An NTCP model to predict radionecrosis after repeat SRS for recurrent brain metastases incorporating time-dependent discounted dose

Prediction of normal tissue complication probability for rat spinal cord tolerance following ion irradiations

A Multi-Center Study of CT-Based Neck Nodal Radiomics for Predicting an Adaptive Radiotherapy Trigger of Ill-Fitted Thermoplastic Masks in Patients with Nasopharyngeal Carcinoma

Redefine the Role of Proton Beam Therapy for the Locally-Advanced Non-Small Cell Lung Cancer Assisting the Reduction of Acute Hematologic Toxicity.

Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer

Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors

Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy

How proton therapy fits into the management of adult intracranial tumors

NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation